Zhang Guowei | Pharmaceutical Sciences | Excellence in Research

Posted on by The Scientist

Mr. Zhang Guowei | Pharmaceutical Sciences | Excellence in Research

Associate Professor |  Hebei University | China

Dr. Zhang Guowei is an active researcher whose work advances the understanding of psychological health, behavioral patterns, and population-level mental well-being, particularly among young adults in contemporary social environments. His academic influence is demonstrated through 347 citations, 20 publications, and an h-index of 10, reflecting a growing global presence and measurable scholarly impact. His research portfolio integrates empirical analysis, psychometric assessment, and digital-behavior analytics to examine how social, environmental, and technological factors shape mental health outcomes. Dr. Zhang’s contributions include impactful studies on anxiety, depression, insomnia, and PTSD among university students, offering timely insights into evolving psychosocial challenges in the post-pandemic era. His work on time-based online survey patterns and their relationship with offline psychological symptoms provides a novel methodological approach, highlighting his ability to connect digital behavioral traces with real-world psychological states. Through these interdisciplinary inquiries, he addresses urgent public-health concerns and informs evidence-based interventions. With a collaborative network spanning over 70 co-authors, Dr. Zhang actively participates in multi-institutional and cross-regional research efforts. This broad collaborative engagement enhances the robustness of his findings and contributes to the global dialogue on mental health resilience, student well-being, and psychosocial risk assessment. His publications in reputable international journals underscore his commitment to research transparency, open access, and data-driven decision-making. Dr. Zhang’s ongoing work strengthens the academic and societal understanding of mental-health dynamics in rapidly changing environments, emphasizing early detection, preventive strategies, and policy relevance. His scholarly trajectory continues to advance applied psychological research, contributing meaningful evidence to public health systems, educational institutions, and community well-being initiatives worldwide.

Profiles: Scopus | ORCID | ResearchGate

Featured Publications

  1. Xiong, J.-M., Wang, J.-Y., Liu, Y., … Zhang, G.-W. (2023). Study on prescription medication mode and mechanism of traditional Chinese medicine in the treatment of noncritical COVID-19 based on data mining.

  2. Fu, Z.-T., Wang, J.-Y., Liu, Y., … Zhang, G.-W. (2023). The mechanism of TCM prevention and treatment of heavy COVID-19 based on data mining and network pharmacology.

  3. Zhang, L.-H., Zhang, W.-Y., Xiong, J.-M., … Zhang, G.-W. (2022). Mechanisms of Compound Kushen Injection for the treatment of bladder cancer based on bioinformatics and network pharmacology with experimental validation.

  4. Cui, Q., Ma, Y., Yu, H., … Zhang, G.-W. (2021). Systematic analysis of the mechanism of hydroxysafflor yellow A for treating ischemic stroke based on network pharmacology technology.

  5. Zhang, L., Zhang, W., Xiong, J., … Zhang, G.-W. (2020). Mechanisms of Compound Kushen Injection for treatment of bladder cancer based on bioinformatics and network pharmacology with experimental validation.

Song-Lin Zhou | Biomedical Sciences | Nanotechnology Innovation Award

Posted on by The Scientist

Dr. Song-Lin Zhou | Biomedical Sciences | Nanotechnology Innovation Award

Research scientist |  School of Tropical Medicine, Hainan Medical University, Haikou, Hainan | China

Dr. Songlin Zhou is a highly productive and influential researcher whose work spans biomedical sciences, network pharmacology, molecular modeling, and bio-nanotechnology. His scholarly contributions demonstrate a sustained commitment to addressing complex medical and biological challenges through integrative, technology-driven approaches. With 576 citations, 37 peer-reviewed publications, and an h-index of 13, Dr. Zhou has established a meaningful presence in the global scientific community. His recent research includes advanced network pharmacology and molecular simulation studies uncovering the mechanisms of therapeutic compounds such as halociline in gastric cancer, as well as pioneering analyses on gut microbial metabolites that elucidate dual-axis pathogenesis in Crohn’s disease. His open-access work on green biosynthesized silver nanoparticles showcases his interdisciplinary strength, contributing to the development of multifunctional hemostatic agents that combine antibacterial, anti-inflammatory, and wound-healing properties. Dr. Zhou’s portfolio reflects wide-ranging international collaboration, with co-authorship across 60 researchers, demonstrating his active engagement in cross-institutional and cross-disciplinary scientific networks. His research not only advances fundamental understanding in disease mechanisms and therapeutic target identification but also supports translational innovation in biomaterials and clinical applications. Through this integrated body of work, Dr. Zhou continues to generate societal impact by contributing to emerging biomedical solutions, strengthening evidence-based therapeutic strategies, and fostering global scientific cooperation.

Profiles: Scopus | ORCID | ResearchGate

Featured Publications

  1. Chen, S., Li, Y., Liu, J., Wu, J., Zhao, H., Cao, R., & Zhou, S. (2025). Gut microbial metabolite crosstalk in Crohn’s disease: Network pharmacology unveils dual-axis pathogenesis and therapeutic targets. BioFactors.

  2. Li, Y., Tan, Y., Zhao, H., Chen, S., Nilghaz, A., Cao, R., & Zhou, S. (2025). Green biosynthetic silver nanoparticles from Ageratum conyzoides as multifunctional hemostatic agents: Combining hemostasis, antibacterial, and anti-inflammatory properties for effective wound healing. Materials Today Bio, 101468.

  3. Zha, X., Li, Y., Zhao, H., Tan, Y., & Zhou, S. (2024). Pyrrolidine, piperazine, and diazinane alkaloids from the marine bacterium strain Vibrio ruber ZXR-93. Molecules, 29(18), 4446.

  4. Zhang, K., Li, X., Yan, C., Shi, R., Fang, Z., Zhou, S., Cao, R., & Tian, J. (2024). All-wood-based ionic power generator with dual functions for alkaline wastewater reuse and energy harvesting. ACS Nano.

  5. Xu, Z., Zha, X., Ji, R., Zhao, H., & Zhou, S. (2023). Green biosynthesis of silver nanoparticles using aqueous extracts of Ageratum conyzoides and their anti-inflammatory effects. ACS Applied Materials & Interfaces.

Ian Freckelton | Biomedical Sciences | Best Researcher Award

Posted on by The Scientist

Prof. Ian Freckelton | Biomedical Sciences | Best Researcher Award 

Professor/Judge/King’s Counsel | University of Melbourne | Australia

Prof. Ian Freckelton AO KC is an eminent Australian barrister, academic, and jurist recognized internationally for his multifaceted contributions to law, psychiatry, and public policy. A King’s Counsel with extensive appellate, trial, and advisory experience, he has practiced across Australia and abroad in administrative, criminal, human rights, and professional negligence law. His exceptional professional standing is reflected in repeated recognition by Doyle’s Guide and Best Lawyers in Australia across public, commercial, and personal injury law categories. He serves as a Judge of the Supreme Court of the Republic of Nauru and has held numerous tribunal roles in mental health, medical regulation, and professional discipline. As Professor of Law and Professorial Fellow in Psychiatry at the University of Melbourne, and Honorary Professor at several leading universities, he bridges legal scholarship and forensic science with a distinctive interdisciplinary approach. A prolific scholar, he has authored and edited over 300 books, chapters, and peer-reviewed papers shaping contemporary discourse in forensic law, expert evidence, and human rights. His research and advocacy have significantly influenced legal reforms, professional accountability, and justice innovation. Ian Freckelton’s academic influence is evidenced by 1,481 citations from 1,163 documents, 313 publications, and an h-index of 15, underscoring his enduring impact on law and society through scholarship, legal practice, and public service.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate

Featured Publications

  1. Freckelton, I. (2020). COVID-19: Fear, quackery, false representations and the law. International Journal of Law and Psychiatry, 72, Article 101611. Citations: 190

  2. Freckelton, I. (2007). Therapeutic jurisprudence misunderstood and misrepresented: Price and risks of influence. Thomas Jefferson Law Review, 30, 575–600. Citations: 180

  3. Denault, V., Plusquellec, P., Jupe, L. M., St-Yves, M., Dunbar, N. E., Hartwig, M., … & Freckelton, I. (2020). The analysis of nonverbal communication: The dangers of pseudoscience in security and justice contexts. Anuario de Psicología Jurídica, 30(1), 1–12. Citations: 117

  4. Bennett, B., McDonald, F., Beattie, E., Carney, T., Freckelton, I., White, B., … & Willmott, L. (2017). Assistive technologies for people with dementia: Ethical considerations. Bulletin of the World Health Organization, 95(11), 749–755. Citations: 115

  5. Freckelton, I. R., & Ranson, D. L. (2006). Death investigation and the coroner’s inquest. Oxford University Press. Citations: 113

ChangLong Wen | Molecular Biology | Best Scholar Award

Posted on by The Scientist

Prof. Dr. ChangLong Wen | Molecular Biology | Best Scholar Award 

Director | Beijing Agriculture And Forestry Academy Of Sciences | China 

Dr. Changlong Wen is a distinguished Professor and Director at the Beijing Vegetable Research Center, Beijing Academy of Agriculture and Forestry Sciences (BAAFS), specializing in vegetable molecular breeding, genomics, and biotechnology. His research has significantly advanced the molecular breeding and improvement of key horticultural crops such as cucumber, watermelon, hot pepper, and zucchini, focusing on traits like yield, disease resistance, and stress tolerance. Dr. Wen’s scientific excellence is reflected in his 2,249 citations, 66 peer-reviewed publications, and an h-index of 29, underscoring his influential contributions to plant science and agricultural biotechnology. He has published in prestigious journals including Nature Communications, Plant Physiology, Plant Biotechnology Journal, and Journal of Integrative Plant Biology. His work on molecular regulation of plant growth and genome-wide gene mining has provided critical insights into crop improvement strategies at both national and international levels. A recipient of numerous national and provincial science awards, Dr. Wen has been honored with distinctions such as the ShenNong Scholar Young Talent (2024), Beijing Scholar Young Talent (2024), and National Talent Program Young Talent (2021). His leadership has contributed to several major Science and Technology Progress Awards, reflecting innovation in genomic breeding technologies and the successful development of high-quality crop varieties. Through his extensive collaborations and translational research, Dr. Wen continues to drive advancements in sustainable agriculture and food security, bridging fundamental plant genomics with applied breeding technologies to benefit both scientific communities and society at large.

Profiles: Scopus | ORCID |ResearchGate

Featured Publications

  1. Zhang, X., … Wen, C. L.* (2025). The natural Msc-4 allele confers genic male sterility via conserved and divergent gene regulatory mechanisms in pepper. Plant Physiology.

  2. Xia, C. X., … Wen, C. L.* (2025). The silicon efflux transporter BEC1 is essential for bloom formation and stress tolerance in cucumber. Journal of Integrative Plant Biology.

  3. Li, Y., … Wen, C. L.* (2025). CAD1 enhances antioxidant activity to facilitate cold storage by regulating flavonoid synthesis in cucumber. Agriculture Communications. (5 citations)

  4. Liu, H., … Wen, C. L.* (2025). Telomere-to-telomere genome assembly of eggplant (Solanum melongena L.) promotes gene fine localization of the green stripe (GS) in pericarp. International Journal of Biological Macromolecules.

  5. Zhou, P., … Wen, C. L.* (2024). Identification of powdery mildew resistance-related genes in butternut squash (Cucurbita moschata). International Journal of Molecular Sciences. (3 citations)

Jan Radford | Pharmaceutical Sciences | Best Researcher Award

Posted on by The Scientist

Prof. Jan Radford | Pharmaceutical Sciences | Best Researcher Award

Prof in General Practice | University of Tasmania | Australia

Professor Jan Radford is a distinguished academic in general practice and medical education, currently based at the Tasmanian School of Medicine, University of Tasmania. With over three decades of professional and academic experience, she has contributed extensively to curriculum design, health professional education, and research capacity building within primary care. She has authored 59 peer-reviewed publications, which have collectively received over 535 citations, reflecting her sustained influence in the field. Professor Radford’s scholarly and leadership contributions span undergraduate, postgraduate, and vocational levels of medical education. As a long-serving faculty member, she has played a pivotal role in shaping the University of Tasmania’s medical curriculum, particularly through initiatives such as the development of innovative rural and aged care placements. Her leadership as Director of the Launceston Clinical School (2022–2024) further strengthened community-based clinical education and interprofessional collaboration across Tasmania. Nationally, she has held major roles in the Royal Australian College of General Practitioners (RACGP), notably serving as Censor-in-Chief, where she oversaw educational quality assurance, specialty recognition, and the advancement of Indigenous health education. Her work in developing the GP MAGIC framework and establishing Tasmania’s practice-based research network has fostered practitioner-led inquiry and evidence-informed primary care. A 2017 Churchill Fellow, Professor Radford investigated the use of routinely collected general practice electronic health data to enhance patient outcomes. This aligns with her ongoing research focus on integrating e-health data, clinical audit, and educational innovation to improve general practice systems and learning environments. Through her extensive collaborations and commitment to translating research into practice, Professor Radford continues to influence healthcare education and delivery in Australia and beyond, contributing meaningfully to the advancement of community-oriented, data-informed primary care.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate

Featured Publications

  1. Watts, G. F., Sullivan, D. R., Hare, D. L., Kostner, K. M., Horton, A. E., Bell, D. A., Brett, T., Radford, J., et al. (2021). Integrated guidance for enhancing the care of familial hypercholesterolaemia in Australia. Heart, Lung and Circulation, 30(3), 324–349. https://doi.org/10.1016/j.hlc.2020.10.013 — 108 citations

  2. Fan, S., Radford, J., & Fabian, D. (2016). A mixed-method research to investigate the adoption of mobile devices and Web 2.0 technologies among medical students and educators. BMC Medical Informatics and Decision Making, 16(1), 43. https://doi.org/10.1186/s12911-016-0282-4 — 52 citations

  3. Bezabhe, W. M., Bereznicki, L. R., Radford, J., Wimmer, B. C., Salahudeen, M. S., et al. (2022). Oral anticoagulant treatment and the risk of dementia in patients with atrial fibrillation: A population-based cohort study. Journal of the American Heart Association, 11(7), e023098. https://doi.org/10.1161/JAHA.121.023098 — 46 citations

  4. Castelino, R. L., Saunder, T., Kitsos, A., Peterson, G. M., Jose, M., Wimmer, B., Radford, J., et al. (2020). Quality use of medicines in patients with chronic kidney disease. BMC Nephrology, 21(1), 216. https://doi.org/10.1186/s12882-020-01849-7 — 37 citations

  5. Bezabhe, W. M., Bereznicki, L. R., Radford, J., Wimmer, B. C., & Curtain, C. (2021). Ten-year trends in the use of oral anticoagulants in Australian general practice patients with atrial fibrillation. Frontiers in Pharmacology, 12, 586370. https://doi.org/10.3389/fphar.2021.586370 — 36 citations

Antonion Zapatero Gaviria | Biomedical Sciences | Best Paper Award

Posted on by The Scientist

Prof. Dr. Antonion Zapatero Gaviria | Biomedical Sciences | Best Paper Award

Jefe de Servicio de Medicina Interna | Hospital Universitario de Fuenlabrada | Spain

Dr. Antonio Zapatero-Gaviria is a distinguished Spanish physician, academic, and public health leader recognized for his outstanding contributions to internal medicine, clinical management, and healthcare policy. He currently serves as Professor of Medicine at the Universidad Rey Juan Carlos and has held pivotal leadership positions within the Spanish healthcare system, including Vice-Minister of Public Health and COVID-19 Response for the Community of Madrid, and Director of the IFEMA Field Hospital during the COVID-19 emergency in 2020. With over four decades of medical and academic experience, Dr. Zapatero-Gaviria has made significant contributions to the advancement of internal medicine and clinical governance. He has authored or co-authored more than 148 scientific publications, garnering over 2,200 citations and achieving an h-index of 27 according to Scopus. His research spans a wide range of topics including infectious diseases, COVID-19 pathophysiology, diabetes care, and health systems management, reflecting both national and international collaborations. A former President of the Spanish Society of Internal Medicine (SEMI) and President of the Federation of Spanish Medical Scientific Associations (FACME), he has played a decisive role in shaping medical standards, professional development, and evidence-based healthcare in Spain. His academic excellence is reflected in three research merit recognitions by ANECA and his induction as a full member of the Real Academia Europea de Doctores in 2024. Dr. Zapatero-Gaviria’s work integrates scientific rigor, leadership in health crisis management, and commitment to the modernization of medical care. His influence extends beyond academia, embodying a model of physician-leadership that bridges clinical excellence, policy innovation, and public service for the betterment of healthcare systems and patient outcomes.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate

Featured Publications

  1. Pairo-Castineira, E., Rawlik, K., Bretherick, A. D., Qi, T., Wu, Y., Nassiri, I., … Zapatero-Gaviria, A. (2023). GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19. Nature, 617(7962), 764–768. https://doi.org/10.1038/s41586-023-06034-3 — 183 citations

  2. Barba, R., Losa, J. E., Velasco, M., Guijarro, C., de Casasola, G. G., & Zapatero, A. (2006). Mortality among adult patients admitted to the hospital on weekends. European Journal of Internal Medicine, 17(5), 322–324. https://doi.org/10.1016/j.ejim.2006.03.008 — 163 citations

  3. Sanchez-Vazquez, R., Guío-Carrión, A., Zapatero-Gaviria, A., Martínez, P., … (2021). Shorter telomere lengths in patients with severe COVID-19 disease. Aging (Albany NY), 13(1), 1–14. https://doi.org/10.18632/aging.202476 — 122 citations

  4. Zapatero, A., Barba, R., Ruiz, J., Losa, J. E., Plaza, S., Canora, J., & Marco, J. (2013). Malnutrition and obesity: influence in mortality and readmissions in chronic obstructive pulmonary disease patients. Journal of Human Nutrition and Dietetics, 26(Suppl. 1), 16–22. https://doi.org/10.1111/jhn.12044 — 116 citations

  5. Marco, J., Barba, R., Zapatero, A., Matía, P., Plaza, S., Losa, J. E., Canora, J., … (2011). Prevalence of the notification of malnutrition in the departments of internal medicine and its prognostic implications. Clinical Nutrition, 30(4), 450–454. https://doi.org/10.1016/j.clnu.2011.01.008 — 103 citations

Taija Juutinen Finni | Biomedical Sciences | Best Researcher Award

Posted on by The Scientist

Prof. Taija Juutinen Finni | Biomedical Sciences | Best Researcher Award

Professor | University of Jyväskylä | Finland

Dr. Taija Juutinen Finni is a distinguished Professor of Kinesiology at the Faculty of Sport and Health Sciences, University of Jyväskylä, Finland, and Vice Dean for Education. With a Ph.D. in Biomechanics (2001) and a Title of Docent in Exercise Physiology (2006), she has built a remarkable academic and research career at the intersection of biomechanics, exercise physiology, and rehabilitation sciences. Her academic training from the University of Jyväskylä, complemented by pedagogical and leadership qualifications, reflects her commitment to education and scientific excellence. Professionally, she has held several pivotal roles, including postdoctoral research at UCLA and multiple research and teaching positions in Finland, before her full professorship in 2010. Dr. Juutinen’s research focuses on muscle-tendon mechanics, Achilles tendon function, physical activity patterns, and rehabilitation in neurological and musculoskeletal disorders, supported by major national and international funding bodies such as the Research Council of Finland and the Ministry of Education and Culture. She has successfully led numerous high-impact projects (e.g., ACHILLES, EXECP, UNRESAT, CHIPASE) and supervised over 18 Ph.D. candidates and 80 M.Sc. theses. Her extensive publication record of 178 scientific papers and two patents underscores her global impact in biomechanics and sports medicine. A sought-after keynote speaker, she has contributed to major international congresses, served on editorial boards of leading journals, and evaluated professorships and grants across Europe and North America. Her awards include the First Class Knight’s Cross of the Order of the White Rose of Finland (2023) and multiple recognitions from international biomechanical societies. A fellow of both the International Society of Biomechanics and the European College of Sport Science, she continues to advance understanding of tendon structure, physical activity, and human performance through cutting-edge interdisciplinary research. Citations: 5,711; documents: 183; h-index: 44.

Profiles: Scopus | ORCID | ResearchGate

Featured Publications

  1. Juutinen, T., et al. (2025). The relationship between triceps surae muscle–tendon morphology and shear modulus across passive ankle range of motion in cerebral palsy. Journal of Biomechanics, 2025. (Open Access).

  2. Juutinen, T., et al. (2025). Medial gastrocnemius muscle and aponeurosis shear wave velocity and morphological changes after Achilles tendon rupture: A 1-year follow-up study. Journal of Biomechanics, 2025. (Open Access).

  3. Juutinen, T., et al. (2025). Physical activity in children and young adults with cerebral palsy: Results from a three-month exercise intervention. European Journal of Sport Science, 2025. (Open Access).

  4. Juutinen, T., et al. (2025). Acute effects of isometric plantarflexion exercise on Achilles tendon non-uniform displacement. Journal of Biomechanics, 2025. (Open Access). Citations: 1

  5. Juutinen, T., et al. (2025). A novel method to assess subject-specific architecture of the Achilles tendon in vivo in humans. Scandinavian Journal of Medicine & Science in Sports, 2025. (Open Access). Citations: 2

Ekadashi Rajni | Biomedical Sciences | Best Researcher Award

Posted on by The Scientist

Dr. Ekadashi Rajni | Biomedical Sciences | Best Researcher Award

Professor | Mahatma Gandhi Medical College & Hospital | India

Dr. E. Rajni Sabharwal, MD in Microbiology, is a leading researcher in clinical microbiology, antimicrobial resistance (AMR), and infection control. Her research focuses on emerging multidrug-resistant and extensively drug-resistant organisms, epidemiology of hospital-acquired infections, and antimicrobial susceptibility patterns in critical clinical settings, including urinary tract and bloodstream infections. She actively contributes to national multicentric studies on AMR surveillance and the implementation of antimicrobial and diagnostic stewardship programs, integrating One Health approaches. Dr. Sabharwal’s work encompasses molecular characterization of pathogens, synergy testing of novel antibiotic combinations, biofilm studies, and evaluation of rapid diagnostic tools to optimize patient management. Her publications address Gram-negative resistance, carbapenem-resistant Enterobacterales, Stenotrophomonas and MRSA infections, fungal pathogens, and empirical management strategies in tertiary care hospitals. She also investigates the role of immunotherapeutic interventions, such as SPAG9-primed dendritic cell-based vaccines, in gallbladder cancer. With expertise in epidemiological research, laboratory diagnostics, and clinical trial design, she has advanced knowledge on antimicrobial stewardship and resistance mitigation. Through workshops, symposia, and mentorship, Dr. Sabharwal promotes evidence-based practices, bridging clinical microbiology with public health strategies to combat AMR and improve patient outcomes, establishing her as a prominent contributor to infectious disease research and translational microbiology. (210 citations by ; 36 Documents; h-index: 8).

Profiles: Google scholar | Scopus | ORCID | ResearchGate

Featured Publications

  1. Sabharwal, E. R. (2012). Antibiotic susceptibility patterns of uropathogens in obstetric patients. North American Journal of Medical Sciences, 4(7), 316. Citations: 106

  2. Sabharwal, E. R., & Sharma, R. (2015). Fosfomycin: An alternative therapy for the treatment of UTI amidst escalating antimicrobial resistance. Journal of Clinical and Diagnostic Research, 9(12), DC06–DC09. Citations: 48

  3. Sabharwal, E. R., & Sharma, R. (2015). Estimation of microbial air contamination by settle plate method: Are we within acceptable limit? Scholars Academic Journal of Biosciences, 3(8), 703–707. Citations: 15

  4. Sabharwal, E. R. (2010). Successful management of Trichosporon asahii urinary tract infection with fluconazole in a diabetic patient. Indian Journal of Pathology and Microbiology, 53(2), 387–388. Citations: 14

  5. Jain, M., Sabharwal, E. R., & Srivastava, D. (2016). Practices of health care personnel regarding occupational exposure. Journal of Clinical and Diagnostic Research, 10(11), DC14–DC17. Citations: 12

Ramin Jaberi | Medical Devices | Best Researcher Award

Posted on by The Scientist

Prof. Dr. Ramin Jaberi | Medical Devices | Best Researcher Award 

Professor | Tehran University of Medical Sciences | Iran

Dr. Ramin Jaberi is a distinguished Medical Physicist specializing in Brachytherapy, Dosimetry, and Monte Carlo Simulation within the field of Radiation Oncology. He earned his Ph.D. in Medical Sciences (2013) from Amsterdam University of Applied Sciences, Netherlands, where he developed a strong foundation in radiation treatment modeling and applied medical physics. Currently serving as a Brachytherapy Physicist at Tehran University of Medical Sciences, Dr. Jaberi brings over two decades of clinical and research experience, contributing extensively to improving cancer radiotherapy accuracy and patient safety. His professional experience includes collaborative projects with prestigious institutions such as the University of Surrey (UK) and participation in IAEA- and ESTRO-supported research initiatives, focusing on optimizing radiation dose distribution and precision therapy. His research interests encompass radiation dose optimization, imaging-based treatment planning, Monte Carlo simulation in radiation transport, and advanced brachytherapy source characterization. Dr. Jaberi’s research skills include expertise in computational modeling, data analysis, radiotherapy system calibration, and experimental dosimetry validation, making him a valuable contributor to the advancement of applied radiation sciences. He has published extensively in Scopus- and IEEE-indexed journals, including numerous Q1-ranked articles addressing clinical and computational aspects of brachytherapy physics. His outstanding academic and clinical contributions have earned him recognition from international medical physics societies and participation in scientific committees and training programs that promote safe radiotherapy practices. A dedicated educator and mentor, he actively supports young researchers in developing computational and analytical approaches to medical physics problems. Dr. Jaberi’s work bridges innovation and clinical application, reflecting a lifelong commitment to enhancing the effectiveness of cancer treatment through research-driven radiotherapy advancements. His consistent scholarly output underscores his impact in biomedical physics, with 385 citations from 337 documents, 56 published papers, and an h-index of 11.

Featured Publications

  1. Naseripour, M., Jaberi, R., Sedaghat, A., Azma, Z., Nojomi, M., Falavarjani, K. G., … (2016). Ruthenium-106 brachytherapy for thick uveal melanoma: Reappraisal of apex and base dose radiation and dose rate. Journal of Contemporary Brachytherapy, 8(1), 66–73.
    Citations: 63

  2. Kalaghchi, B., Esmati, E., Ghalehtaki, R., Gomar, M., Jaberi, R., Gholami, S., … (2018). High-dose-rate brachytherapy in treatment of non-melanoma skin cancer of head and neck region: Preliminary results of a prospective single institution study. Journal of Contemporary Brachytherapy, 10(2), 115–122.
    Citations: 35

  3. Naseripour, M., Maleki, A., Astaraki, A., Sedaghat, A., Jaberi, R., Lee, S., Azma, Z., … (2018). Ruthenium-106 brachytherapy in the treatment of circumscribed choroidal hemangioma. Retina, 38(5), 1024–1030.
    Citations: 32

  4. Allahverdi, M., Sarkhosh, M., Aghili, M., Jaberi, R., Adelnia, A., & Geraily, G. (2012). Evaluation of treatment planning system of brachytherapy according to dose to the rectum delivered. Radiation Protection Dosimetry, 150(3), 312–315.
    Citations: 28

  5. Siavashpour, Z., Aghamiri, M. R., Jaberi, R., Manshadi, H. R. D., & Ghaderi, R. (2016). Optimum organ volume ranges for organs at risk dose in cervical cancer intracavitary brachytherapy. Journal of Contemporary Brachytherapy, 8(2), 135–142.
    Citations: 27

Shoubhik Chakraborty | Biomedical Sciences | Best Researcher Award

Posted on by The Scientist

Dr. Shoubhik Chakraborty | Biomedical Sciences | Best Researcher Award

Pediatric Optometrist | Kalinga Institute of Medical Sciences | India

Mr. Shoubhik Chakraborty is a dedicated Clinical Optometrist specializing in Pediatric Optometry, Cerebral Visual Impairment (CVI), Binocular Vision, Neuro-Optometry, and Behavioral Optometry. He completed his Bachelor’s degree in Clinical Optometry and Vision Science (2017–2021) from NSHM College of Management and Technology, MAKAUT University, Durgapur, followed by a Fellowship in Pediatric Optometry, Binocular Vision, and Cerebral Visual Impairment (2021–2023) at Narayana Nethralaya, Bangalore. His academic foundation was built at Karaiya High School and Sagardighi Thermal Power School, affiliated with WBBSE and WBCHSE respectively. Professionally, Mr. Chakraborty began his clinical training at MGM Eye Institute, Raipur, where he gained hands-on experience in hospital-based vision care. He later worked as a Cerebral Visual Impairment Specialist at AIIMS, Jodhpur, demonstrating excellence in managing pediatric and neuro-optometric cases, and is currently serving as a Pediatric Optometrist at KIMS Hospital, Bhubaneswar, where he continues to advance patient outcomes through customized vision therapy and diagnostic precision. His research interests encompass neuro-visual rehabilitation, visual neuroplasticity, binocular dysfunctions, amblyopia management, and pediatric refractive errors. He has developed strong research skills in clinical data interpretation, vision assessment methodologies, and evidence-based optometric intervention design. Mr. Chakraborty has contributed scholarly papers, including publications in Optometry and Visual Performance, and presented his findings at prestigious forums such as the Asia Pacific Optometry Summit (2018), Bengal Optometry Conference (2020), and Karnataka Optometry Conference (2022). Recognized for his leadership, teamwork, and clinical innovation, he exemplifies a balance of academic rigor and compassionate care. His achievements reflect a commitment to advancing pediatric visual science through both clinical excellence and research innovation. With his growing expertise, professional dedication, and vision for future advancements, Mr. Shoubhik Chakraborty is poised to emerge as a leading figure in neuro-visual and pediatric optometry research and practice in India and beyond.

Profiles: Google Scholar | ORCID  | ResearchGate

Featured Publications

  1. Chakraborty, S., Sarbajna, P., Vinekar, A., & Shetty, B. (2024). Outcomes of vision therapy among children with cerebral visual impairment: A retrospective study. Optometry and Visual Performance, 12 (1).

  2. Chakraborty, S., & Parida, S. (2025). Effect of vision therapy on cerebral visual impairment: Insights from three pediatric cases. Advances in Ophthalmology and Visual System (AOVS), 15 (2).

  3. Chakraborty, S. D., & Hajira, R. (2025). Recovering vision and binocularity in a presbyopic patient with amblyopia. Vision Development and Rehabilitation (VDR), 11 (1), 48.

  4. Chakraborty, S., Parida, S., Mohanty, S. K., Das, M., Dash, S., & Mohanty, S. (2025). Prevalence of accommodative insufficiency in children with normal accommodative-convergence/accommodation ratio and its association with refractive error: A cross-sectional study. Cureus, 17 (2).

  5. Chakraborty, S., Parida, S., & Mohanty, S. K. (2025). Effect of vision therapy on cerebral visual impairment: Insights from three pediatric cases. Advances in Ophthalmology and Visual System, 15 (2), 82–85.